LAKE TAHOE, Nev., Oct. 29, 2024 (GLOBE NEWSWIRE) - 2ONE Labs Inc., is pleased to announce the 'Acceptance' of its Premarket Tobacco Product Application (PMTA) submission by the U.S. Food and Drug Administration for its 2ONE® branded nicotine pouches.
Acknowledging receipt of the FDA ‘Acceptance’ notification, Vincent Schuman, CEO of 2ONE Labs, said: “This means the 2ONE® PMTA application will now move forward to the next important stage of FDA review. Our company will continue to fully fund this submission to a successful conclusion, and our wholesale, retail and sponsorship partners should take confidence in this ‘Acceptance’ as a sign of our ability to navigate this complex PMTA process, and of our unwavering commitment to support the long-term availability of the 2ONE® brand in the US market.”
Schuman added: “We created 2ONE® nicotine pouches for adult users (21+), who find it challenging to switch from combustible or traditional oral tobacco-leaf products. The availability of the 2ONE® brand in the market over the past 5 years, and the interest and growth our brand has achieved through strong retail partnerships, such as with CircleK®, has shown it is possible - even for innovative companies - to identify and introduce unique brands that truly offer adults the perfect switching product. We are encouraged by FDA’s acceptance of the 2ONE® PMTA submission and we look forward to continuing to support the needs of adult consumers switching from tobacco.”
2ONE® nicotine pouch products are offered in a variety of nicotine levels and satisfying flavors at over 18,000 retail outlets nationwide, and can be purchased online by adult consumers at: 21Pouches.com.
About 2ONE® Nicotine Pouches
2ONE Labs Inc.: Founded by pioneers in synthetic nicotine production, 2ONE Labs specializes in providing the most innovative tobacco-free nicotine products to adult consumers seeking an alternative to other tobacco products. For more information, contact 21Pouches.com. 2ONE® is a registered trademark of 2ONE Labs Inc., Lake Tahoe, NV. All Rights Reserved.
Source: 2ONE LABS INC.
Contact:
Vincent@21pouches.com
- 广州四维营销:会议会务全托管,让企业招商会 “落地即成交”
- 平安人寿联合复旦大学重磅发布《新纪元·新价值:迎接黄金发展期》寿险行业白皮书
- 2025亚洲国际音乐大赛新加坡总决赛颁奖典礼精彩纷呈
- 十一度蝉联保险业第一!BrandZ《最具价值中国品牌100强》发布:中国平安位列中国品牌第九
- 3岁女童总爱凑近皱眉看人,检查竟非近视,而是得了“老年病”——福州爱尔眼科
- 2025上海别墅装修公司有哪些?高性价比推荐:1299 元 /㎡享品质装修
- 千金药业:1.5亿智能车间圆满封顶 女性健康产业升级加速
- 林华寿独创道家古法疗法攻克三尸虫取得重大突破
- 新愿景,新启航!研华加速从IPC迈入边缘计算新时代
- PIK3CA基因检测助力乳腺癌精准治疗新篇章
- 伽澜健康助力黄河金三角区域医疗机构临床营养学科建设论坛圆满举办
- 立屯精神聚合力 政企共建助振兴—中国人寿财险广西分公司联合天等县开展主题党日活动
- 《StellarSugar》12强选手惊现韩国最大中餐厅:燕京大饭店
- 有梦有方向 青春正飞扬 “青春影像”校园歌手征集最终展示活动将在重庆举办
- 山东双嘉家庭教育走进历城一中:开展心理讲座赋能青春梦想